Beyond Weight Loss: Eli Lilly’s Next-Gen Triple-Hormone Drug Retatrutide Slashes Sleep Apnea Severity and Knee Pain in Phase 3 Trials
NEW ORLEANS — June 6, 2026 — In a milestone development that could fundamentally reshape the treatment of obesity and its most debilitating...
Beyond the Plateau: Roche’s Next-Gen Obesity Drug Sparks New Hope with 22.7% Weight Loss in Mid-Stage Trial
Dharamsala, Himachal Pradesh — June 7, 2026 Swiss pharmaceutical giant Roche announced Friday that its experimental, dual-acting obesity medication,...
US Medical Missionary Discharged After Recovering From Rare Ebola Strain in Berlin Hospital
BERLIN, Germany — Medical officials at Charité–Universitätsmedizin Berlin announced the official discharge of Dr. Peter Stafford on Saturday, June...
Pfizer’s Monthly Obesity Shot Shows Wegovy-Like Side Effects in Midstage Trial, Offering Convenient Dosing Option
Published: June 7, 2026 | New Orleans, LA NEW ORLEANS — On Saturday at the American Diabetes Association (ADA) Scientific Sessions, Pfizer presented...
From Code to Clinic: World’s First AI-Designed Vaccine Enters Human Trials
OXFORD, UK — In what scientists are calling a historic watershed moment for modern medicine, the world’s first vaccine designed through artificial...
